...
首页> 外文期刊>Acta Cardiologica >Long (> or = 25 mm) stents for long coronary artery lesions. A safe conduct or a bridge too far for the interventional cardiologist?
【24h】

Long (> or = 25 mm) stents for long coronary artery lesions. A safe conduct or a bridge too far for the interventional cardiologist?

机译:用于长冠状动脉病变的长支架(>或= 25 mm)。安全的行为或对介入心脏病学家而言太过遥远的桥梁?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Increased restenosis rates have been reported after stenting long lesions with multiple standard length stents. Long slotted tube stents have become available for the treatment of long lesions or dissections.To compare clinical outcome after the use of long Multi-Link stents in long coronary lesions versus standard length Multi-Link stents in Benestent type lesions. METHODS AND RESULTS: We evaluated clinical outcome (six months) of 147 consecutive patients in whom one or more > or = 25 mm long Multi-Link stents were successfully deployed.The results were compared with the West-2 registry in which a 15 mm Multi-Link stent was used. The patients with long stents had more complex lesions and unstable symptoms. Target lesion revascularization after six months follow-up was comparable with that observed after implantation of a standard length stent (6.9% vs. 6.1%, p = 0.81). Overall cardiac event-free survival was similar for both groups (89.7% vs. 91.5%, p = 0.73). CONCLUSIONS: Patients treated with one or more long (> or = 25 mm) Multi-Link stents have a similar event-free survival and an equivalent target lesion repeat revascularization risk after six months than patients treated with a standard length stent.
机译:目的:已有报道称,使用多个标准长度的支架将长的病变置入支架后,再狭窄率增加。长缝管支架已经可以用于治疗长病变或解剖。为了比较在长冠状动脉病变中使用长Multi-Link支架与在Benestent型病变中使用标准长度Multi-Link支架后的临床结果。方法和结果:我们评估了147例连续成功部署了一个或多个>或= 25 mm长的Multi-Link支架的连续患者的临床结局(六个月),并将结果与​​West-2注册表中的15 mm进行了比较使用多连杆支架。支架较长的患者病灶较复杂,症状不稳定。六个月的随访后靶病变血运重建与标准长度支架植入后观察到的相当(6.9%vs. 6.1%,p = 0.81)。两组的总体无事件生存率相似(89.7%vs. 91.5%,p = 0.73)。结论:与使用标准长度支架治疗的患者相比,使用一个或多个长(>或= 25 mm)Multi-Link支架治疗的患者六个月后具有无事件生存率和相等的靶病变重复血运重建风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号